Jun. 7, 2013, 10:21 AMShares of Cantel Medical (CMN +0.9%) rise a day after the company reported Q3 results that met expectations. Piper Jaffray (Overweight) analyst Thomas Gunderson says CMN has "a strong management team that … can keep EPS growing with further acquisitions, higher margin new products, and tight expense controls." Price target raised to $40 from $35. | Comment!
Mar. 7, 2013, 1:53 PMCantel Medical (CMN -1%) fades off a 52-week high on profit-taking today after company posted a mixed FQ2 earnings report, missing on revenue estimates. Sales hit a record however, driven by a 36% Y/Y increase from its healthcare disposables segment. Organic sales growth was 11%, about half of which was driven by distributor customers pulling forward shipments in anticipation of January 1 price increases. | Comment!
Oct. 11, 2012, 12:45 PM
Oct. 11, 2012, 8:47 AM
Oct. 13, 2011, 2:49 PM
CMN vs. ETF Alternatives
Cantel Medical Corp provides infection prevention and control products in the healthcare market. Its operating segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, and Specialty Packaging.
Other News & PR